Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Kuwait

Kuwait Articles

Industry

BMI View: Attempts in the Gulf region to take a more preventative stance against public health issues is commendable, but changing attitudes and weaning the population of their tobacco... 2012-02-01


Industry

BMI View: We warned throughout 2011 that drug pricing controls were likely to spread within the Gulf Cooperation Council (GCC). The establishment of a joint GCC drug pricing unit vindicates... 2012-01-11


Industry

BMI View: Kuwait's healthcare system is undergoing a period of transition from a primarily state-run public healthcare system to an increased number of public-private partnerships (PPPs),... 2011-12-12


More ARTICLES

Industry

BMI View: While the biotechnology parks of Dubai and Saudi Arabia have attracted some big names in the global industry, we are concerned that they may have become glorified tax havens... 2011-11-09


Industry

BMI View: A free trade agreement (FTA) between India and the Gulf Cooperation Council (GCC) will help Indian drugmakers to take a greater market share of the generic drug segment, primarily... 2011-10-13


Industry

BMI View: Kuwait's healthcare system is undergoing a period of transition from a primarily state-run public healthcare system to an increased number of public-private partnerships (PPPs),... 2011-08-17


Industry

BMI View: The formation of The Gulf Federation of Manufacturers of Pharmaceuticals and Medical Supplies (GFMPMS) in Doha is, potentially, a very significant move towards the regulatory... 2011-06-13


Industry

BMI View: Public regulatory bodies in emerging markets will become increasingly involved in reducing the prices of pharmaceuticals. Multinational drugmakers are looking to offset fiscal... 2011-04-26

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries